Omega-3 fatty acids: A potential future treatment for asthma?

Expert Review of Respiratory Medicine

Volumn 7, Issue 6, 2013, Pages 577-580

  Mickleborough, Timothy D ^a   Lindley, Martin R ^b  

^a INDIANA UNIVERSITY   (United States)

^b LOUGHBOROUGH UNIVERSITY   (United Kingdom)

Author keywords

Asthma; Diet; Inflammation; Omega 3 fatty acids

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 13; LIPOXYGENASE; METHACHOLINE; OMEGA 3 FATTY ACID; PHOSPHOLIPASE A2; PHOSPHOLIPID; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; THROMBOXANE; TRIACYLGLYCEROL;

AIRWAY OBSTRUCTION; ALLERGIC AIRWAY INFLAMMATION; ASTHMA; BLEEDING; BLOATING; BRONCHOSPASM; CELL MEMBRANE; CHILD; CHRONIC LUNG DISEASE; DIARRHEA; DIET SUPPLEMENTATION; FLATULENCE; FORCED EXPIRATORY VOLUME; GENE CONTROL; HEALTH CARE COST; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LUNG FUNCTION; MORBIDITY; MORTALITY; NONHUMAN; PERNA CANALICULUS; PHENOTYPE; QUALITY OF LIFE; RESPIRATORY TRACT INFLAMMATION; REVIEW; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ASTHMA; FATTY ACIDS, OMEGA-3; HUMANS; PHENOTYPE; TREATMENT OUTCOME;

EID: 84888122246     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/17476348.2013.841080     Document Type: Review

References (20)

1. Horrobin DF. Low prevalences of coronary heart disease (CHD), psoriasis, asthma and rheumatoid arthritis in Eskimos: are they caused by high dietary intake of eicosapentaenoic acid (EPA), a genetic variation of essential fatty acid (EFA) metabolism or a combination of both? Med. Hypotheses 22(4), 421-428 (1987).
2. Serhan CN. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu. Rev. Immunol. 25, 101-137 (2007).
3. Mickleborough TD, Lindley MR, Ionescu AA, Fly AD. Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma. Chest 29(1), 39-49 (2006).
4. Mickleborough TD, Tecklenburg SL, Montgomery GS, Lindley MR. Eicosapentaenoic acid is more effective than docosahexaenoic acid in inhibiting proinflammatory mediator production and transcription from LPS-induced human asthmatic alveolar macrophage cells. Clin. Nutr. 28(1), 71-77 (2009).
5. Tecklenburg-Lund S, Mickleborough TD, Turner LA, Fly AD, Stager JM, Montgomery GS. Randomized controlled trial of fish oil and montelukast and their combination on airway inflammation and hyperpnea-induced bronchoconstriction. PLoS ONE 5(10), e13487 (2010).
6. Dry J, Vincent D. Effect of a fish oil diet on asthma: results of a 1-year double-blind study. Int. Arch. Allergy Appl. Immunol. 95(2-3), 156-157 (1991).
7. Nagakura T, Matsuda S, Shichijyo K, Sugimoto H, Hata K. Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma. Eur. Respir. J. 16(5), 861-865 (2000).
8. Biltagi MA, Baset AA, Bassiouny M, Kasrawi MA, Attia M. Omega-3 fatty acids, vitamin C and Zn supplementation in asthmatic children: a randomized self-controlled study. Acta Paediatr. 98(4), 737-742 (2009).
9. Broughton KS, Johnson CS, Pace BK, Liebman M, Kleppinger KM. Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production. Am. J. Clin. Nutr. 65(4), 1011-1017 (1997).
10. Schubert R, Kitz R, Beermann C et al. Effect of n-3 polyunsaturated fatty acids in asthma after low-dose allergen challenge. Int. Arch. Allergy Immunol. 148(4), 321-329 (2009).
11. Sallam M, Motaleb F, Ahmed M, Mahmoud A. Anti-inflammatory effect of Omega-3 polyunsaturated fatty acids in children with bronchial asthma; relation to nuclear factor-kappa B (NF-κB) and inflammatory cytokines IL-12 and IL-13. Egypt. J. Biochem. Mol. Biol. 28(2), (2010).
12. Mihrshahi S, Peat JK, Marks GB et al. Eighteen-month outcomes of house dust mite avoidance and dietary fatty acid modification in the Childhood Asthma Prevention Study (CAPS). J. Allergy Clin. Immunol. 111(1), 162-168 (2003).
13. Kremmyda LS, Vlachava M, Noakes PS, Diaper ND, Miles EA, Calder PC. Atopy risk in infants and children in relation to early exposure to fish, oily fish, or long-chain omega-3 fatty acids: a systematic review. Clin. Rev. Allergy Immunol. 41(1), 36-66 (2011).
14. Thien FC, De Luca S, Woods RK, Abramson MJ. Dietary marine fatty acids (fish oil) for asthma in adults and children. Cochrane Database Syst. Rev. (2), CD001283 (2010).
15. Mickleborough TD, Vaughn CL, Shei R-J, Davis EM, Wilhite DP. Marine lipid fraction PCSO-524 (lyprinol/omega XL) of the New Zealand green lipped mussel attenuates hyperpnea-induced bronchoconstriction in asthma. Respir. Med. 197, 1152-1163 (2013).
16. Emelyanov A, Fedoseev G, Krasnoschekova O, Abulimity A, Trendeleva T, Barnes PJ. Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial. Eur. Respir. J. 20(3), 596-600 (2002).
17. Wood LG, Hazlewood LC, Foster PS, Hansbro PM. Lyprinol reduces inflammation and improves lung function in a mouse model of allergic airways disease. Clin. Experiment. Allergy 40(12), 1785-1793 (2010).
18. Wakimoto T, Kondo H, Nii H et al. Furan fatty acid as an anti-inflammatory component from the green-lipped mussel Perna canaliculus. Proc. Natl Acad. Sci. U.S.A. 108(42), 17533-17537 (2011).
19. Bouchard-Mercier A, Rudkowska I, Lemieux S, Couture P, Vohl M-C. Polymorphisms, de novo lipogenesis and plasma triglyceride response following fish oil supplementation. J. Lipid Res. (2013).
20. Fortenko O, Zeki A, Schuster G et al. Asthma patients with specific genotypes identified for fish oil treatment trial. Calif. Agr. 65(3), 112-117 (2011).